: 2025 revenue hit £32.7bn (up 7%), driven by high-margin specialty medicines like HIV and Respiratory treatments.
: The total 2025 dividend was 66p (up 8.2% from 2024). Management has signaled an expected increase to 70p for 2026. buy gsk shares
Investors are "piling into" GSK due to several key shifts in the company's fundamentals: : 2025 revenue hit £32
We're taking you over to a different website and it may have a different privacy policy than ours. We just needed to let you know.
For more information regarding our Linking Policy and Endorsement, click here.
For more information regarding our policy on the use of third-party websites and applications, click here.
For more information about protecting your privacy and personal information, click here.
If you want to head back, hit cancel.
Continue